000 01255 a2200349 4500
005 20250517170332.0
264 0 _c20180608
008 201806s 0 0 eng d
022 _a1573-4935
024 7 _a10.1042/BSR20170685
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYan, Bin
245 0 0 _aGlibenclamide induces apoptosis by activating reactive oxygen species dependent JNK pathway in hepatocellular carcinoma cells.
_h[electronic resource]
260 _bBioscience reports
_cOct 2017
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCarcinoma, Hepatocellular
_xdrug therapy
650 0 4 _aCell Line, Tumor
650 0 4 _aGlyburide
_xpharmacology
650 0 4 _aHep G2 Cells
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xpharmacology
650 0 4 _aLiver Neoplasms
_xdrug therapy
650 0 4 _aMAP Kinase Signaling System
_xdrug effects
650 0 4 _aReactive Oxygen Species
_xmetabolism
700 1 _aPeng, Zhiyong
700 1 _aXing, Xiao
700 1 _aDu, Chunling
773 0 _tBioscience reports
_gvol. 37
_gno. 5
856 4 0 _uhttps://doi.org/10.1042/BSR20170685
_zAvailable from publisher's website
999 _c27459048
_d27459048